Regulation - PTC Therapeutics

Filter

Current filters:

PTC Therapeutics

Popular Filters

CHMP changes mind on PTC Therapeutics’ Duchenne drug Translarna, giving a positive opinion

25-05-2014

In something of a surprise for PTC Therapeutics and observers, the European Medicines Agency’s advisory…

BiotechnologyEuropePTC TherapeuticsRare diseasesRegulationTranslarna

Company Spotlight

ImmunoGen

ImmunoGen

Back to top